Kaken Pharmaceutical Co Ltd 2023 Integrated Report
The report covers FY2022 performance, including net sales of ¥72,984 million. The company established a Sustainability Committee and adopted TCFD recommendations, while setting its own goal to reduce CO2 emissions by 51% by FY2030 compared with FY2016 levels.
Company: Kaken Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 47
Back to company
Kaken Pharmaceutical Co Ltd
Corporate Report
The report covers FY2022 performance, including net sales of ¥72,984 million. The company established a Sustainability Committee and adopted TCFD recommendations, while setting its own goal to reduce CO2 emissions by 51% by FY2030 compared with FY2016 levels.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Net Zero Target
Employees